Structures of two chemokine receptor proteins in complex with small molecules reveal a previously unknown binding pocket that could be a drug target for treating a range of diseases involving this receptor family. See Letters p.458 & p.462
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Oswald, C. et al. Nature 540, 462–465 (2016).
Zheng, Y. et al. Nature 540, 458–461 (2016).
De Lean, A., Stadel, J. M. & Lefkowitz, R. J. J. Biol. Chem. 255, 7108–7117 (1980).
Zweemer, A. J. M. et al. Mol. Pharmacol. 84, 551–561 (2013).
Tchernychev, B. et al. Proc. Natl Acad. Sci. USA 107, 22255–22259 (2010).
Staus, D. P. et al. Nature 535, 448–452 (2016).
Burg, J. S. et al. Science 347, 1113–1117 (2015).
Rasmussen, S. G. F. et al. Nature 477, 549–555 (2011).
Kang, T. et al. Nature 523, 561–567 (2015).
Qin, L. et al. Science 347, 1117–1122 (2015).
Veldkamp, C. T. et al. Sci. Signal. 1, ra4 (2008).
Tan, Q. et al. Science 341, 1387–1390 (2013).
Author information
Authors and Affiliations
Corresponding authors
Related links
Related links
Related links in Nature Research
Drug discovery: Designing the ideal opioid
Structural biology: Arresting developments in receptor signalling
Rights and permissions
About this article
Cite this article
Sakmar, T., Huber, T. Inside-out receptor inhibition. Nature 540, 344–345 (2016). https://doi.org/10.1038/nature20486
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature20486
This article is cited by
-
Trends in GPCR drug discovery: new agents, targets and indications
Nature Reviews Drug Discovery (2017)